Reports for ALLERGAN INC

Company Name

ALLERGAN INC

Totals

Shortage reports

30

Actual shortage: 3 (10%)
Anticipated shortage: 0 (0%)
Avoided shortage: 0 (0%)
Resolved: 27 (90%)

Discontinuation Reports

2

To be discontinued: 0 (0%)
Discontinued: 2 (100%)
Reversed: 0 (0%)

Late reports

6 (19%)

Overdue reports

1 (33%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TAZORAC 0.05% GEL Resolved 2018-11-01 2019-05-18 65978
VIIBRYD 10MG TABLET Resolved 2019-02-28 2019-05-14 77159
VIIBRYD 20MG TABLET Resolved 2019-01-15 2019-05-09 72342
OZURDEX 0.7MG IMPLANT Resolved 2019-04-08 2019-04-27 80819
ACUVAIL 0.45% SOLUTION Resolved 2019-03-20 2019-04-26 78953
BLEPHAMIDE OPHT SUSPENSION 0.2% 10% DROPS Resolved 2019-03-03 2019-04-19 77342
BLEPHAMIDE OPHT SUSPENSION 0.2% 10% DROPS Resolved 2019-03-03 2019-04-15 77338
OZURDEX 0.7MG IMPLANT Resolved 2019-02-21 2019-03-21 76570
ACULAR LIQ 0.5% 0.5% SOLUTION Resolved 2019-02-15 2019-03-15 75873
VIIBRYD 10MG TABLET Resolved 2019-01-15 2019-02-28 72344
CONSTELLA 290MCG CAPSULE Resolved 2019-02-19 2019-02-27 76263
BYSTOLIC 10.0MG TABLET Resolved 2019-01-29 2019-02-22 73787
ACULAR LIQ 0.5% 0.5% SOLUTION Resolved 2018-11-06 2019-02-21 66328
BYSTOLIC 5.0MG TABLET Resolved 2018-12-05 2019-02-08 68675
RESTASIS MULTIDOSE 0.05% EMULSION Actual shortage 2019-02-01 2019-02-01 74356
ALPHAGAN P 0.15% SOLUTION Resolved 2019-01-21 2019-01-23 73016
CONSTELLA 290MCG CAPSULE Resolved 2018-11-20 2019-01-09 67153
TAZORAC 0.1% GEL Resolved 2018-11-02 2018-12-01 66125
TAZORAC 0.05% CREAM Resolved 2018-11-02 2018-12-01 66116
OXYTROL 36MG PATCH Resolved 2018-09-25 2018-11-03 62335

Showing 1 to 20 of 30

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
ALOCRIL 2% LIQUID Discontinued 2018-11-28 2019-04-02 67803
BETAGAN OPH SOLN 0.25% 0.25% LIQUID Discontinued 2017-08-04 2017-08-04 18275